PTG-100 peptide: Clinical Trials

1 trial of PTG-100 peptide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow PTG-100 peptide: new trials by email Literature Review of PTG-100 peptide trials Research Report on PTG-100 peptide

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis
PTG-100, Placebo - Ulcerative Colitis
Phase 2TerminatedProtagonist Therapeutics, Inc.982016-12-012025-08-21

Conditions studied

Colitis, Ulcerative (1)  ·  Inflammatory Bowel Diseases (1)

Sponsors

Protagonist Therapeutics, Inc. (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Bosnia and Herzegovina (1)  ·  Canada (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Latvia (1)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Poland (1)  ·  Russia (1)  ·  Serbia (1)  ·  South Korea (1)

Results publications

PMID 34474038